High-dose radiation treatment may efficiently change the immunological microenvironment of mouse colon tumors, especially CT26 and MC38, producing complete remissions. Although the research reveals that a single radiation dosage of 30 Gy causes notable alterations, like enhanced CD8+ T cell infiltration and reduced myeloid-derived suppressor cells (MDSCs), these tumors are poorly immunogenic, which presents obstacles to therapy. The procedure generates a strong anti-tumor immune response driven by IFN-γ using antigen cross-presentation by CD8+ dendritic cells and the activity of CD4+ T cells.
Figure 1. The researchers transduced CT26 cells with a GFP-firefly luciferase fusion gene, enhancing transduction efficiency to create a stable cell line for tumor immune studies. (Filatenkov A, et al., 2015)
Creative Biogene's Luc/GFP Reporter Cell Line-CT26 product is designed for researchers exploring similar immune response dynamics in tumor studies. This stable cell line, engineered for bioluminescence and fluorescence, allows for real-time monitoring of tumor behavior and immune interactions in vivo.
Customer Reviews
Accuracy
In the process of obtaining data using the Luc/GFP Reporter Cell Line-CT26 product, I found the results to be very reliable. This cell line has demonstrated good reproducibility and consistency, both within the lab and in communication with other research teams. This gives me confidence in the results of my experiments and facilitates collaboration and communication with others.
Write a Review